임상용 웨어러블 모니터링 기기 시장 규모, 점유율, 동향 분석 보고서 : 연결성별, 용도별, 제품별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

Clinical Wearable Monitoring Devices Market Summary

The global clinical wearable monitoring devices market size was valued at USD 22.0 billion in 2025 and is projected to grow from USD 24.8 billion in 2026 to USD 65.2 billion by 2033, at a CAGR of 14.8% from 2026 to 2033. The market in North America dominated with a revenue share of 39.3% in 2025. This growth is attributed to the growing adoption of remote patient monitoring, rising prevalence of chronic diseases, advancements in wearable sensors and connectivity, and expansion of clinical-grade wearable products.

Global Clinical Wearable Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global clinical wearable monitoring devicesmarket report based on product, connectivity, application, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Wearable ECG/Heart Rhythm Monitors
• Wearable Blood Pressure Monitors
• Wearable Pulse Oximeters
• Continuous Glucose Monitoring Devices
• Wearable Temperature Monitors
• Wearable Respiratory Monitors
• Wearable Multimodal Patient Monitors
• Wearable Neurological Monitors
• Other
• Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
• Bluetooth
• Wi-Fi
• Cellular
• Other Connectivity Technologies
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Cardiovascular
• Diabetes
• Respiratory
• Neurological
• Postoperative
• Remote Patient Monitoring
• Other Applications (Sleep, Maternal & Fetal, etc.)
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals & Clinics
• Home Healthcare
• Ambulatory Care Centers
• Long-term Care Facilities
• Other
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Connectivity
  • 1.2.3. Application
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Adoption of Remote Patient Monitoring
    • 3.2.1.2. Rising Prevalence of Chronic Diseases
    • 3.2.1.3. Advancements in Wearable Sensors and Connectivity
    • 3.2.1.4. Expansion of Clinical-Grade Wearable Products
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Data Privacy and Cybersecurity Concerns
    • 3.2.2.2. Limited Clinical Integration and Interoperability
  • 3.2.3. Industry Opportunity Analysis
  • 3.2.4. Industry Challenge Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal Landscape

Chapter 4. Clinical Wearable Monitoring Devices Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Product Market Share Movement Analysis, 2025 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Wearable ECG/Heart Rhythm Monitors
  • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Wearable Blood Pressure Monitors
  • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Wearable Pulse Oximeters
  • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.7. Continuous Glucose Monitoring Devices
  • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.8. Wearable Temperature Monitors
  • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.9. Wearable Respiratory Monitors
  • 4.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.10. Wearable Multimodal Patient Monitors
  • 4.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.11. Wearable Neurological Monitors
  • 4.11.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.12. Other
  • 4.12.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Clinical Wearable Monitoring Devices Market: Connectivity Estimates & Trend Analysis

• 5.1. Connectivity Segment Dashboard
• 5.2. Connectivity Market Share Movement Analysis, 2025 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
• 5.4. Invasive Ventilation
  • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Bluetooth
  • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Wi-Fi
  • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Cellular
  • 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Other Connectivity Technologies
  • 5.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Clinical Wearable Monitoring Devices Market: Application Estimates & Trend Analysis

• 6.1. Application Segment Dashboard
• 6.2. Application Market Share Movement Analysis, 2025 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Cardiovascular
  • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Diabetes
  • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Respiratory
  • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Neurological
  • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Postoperative
  • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Remote Patient Monitoring
  • 6.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.10. Other Applications (Sleep, Maternal & Fetal etc.)
  • 6.10.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Clinical Wearable Monitoring Devices Market: End Use Estimates & Trend Analysis

• 7.1. End use Segment Dashboard
• 7.2. End use Market Share Movement Analysis, 2025 & 2033
• 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Hospitals & Clinics
  • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Home Healthcare
  • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Ambulatory Care Centers
  • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.8. Long-term Care Facilities
• 7.9. Other
  • 7.9.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Clinical Wearable Monitoring Devices Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Dashboard
• 8.2. Regional Market: Key Takeaways
• 8.3. North America
  • 8.3.1. North America clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key country dynamic
    • 8.3.2.2. Regulatory framework
    • 8.3.2.3. Competitive insights
    • 8.3.2.4. U.S. clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key country dynamic
    • 8.3.3.2. Regulatory framework
    • 8.3.3.3. Competitive insights
    • 8.3.3.4. Canada clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key country dynamic
    • 8.3.4.2. Regulatory framework
    • 8.3.4.3. Competitive insights
    • 8.3.4.4. Mexico clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamic
    • 8.4.2.2. Regulatory framework
    • 8.4.2.3. Competitive insights
    • 8.4.2.4. Germany clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.3. UK
    • 8.4.3.1. Key country dynamic
    • 8.4.3.2. Regulatory framework
    • 8.4.3.3. Competitive insights
    • 8.4.3.4. UK clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key country dynamic
    • 8.4.4.2. Regulatory framework
    • 8.4.4.3. Competitive insights
    • 8.4.4.4. France clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key country dynamic
    • 8.4.5.2. Regulatory framework
    • 8.4.5.3. Competitive insights
    • 8.4.5.4. Italy clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key country dynamic
    • 8.4.6.2. Regulatory framework
    • 8.4.6.3. Competitive insights
    • 8.4.6.4. Spain clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key country dynamic
    • 8.4.7.2. Regulatory framework
    • 8.4.7.3. Competitive insights
    • 8.4.7.4. Denmark clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key country dynamic
    • 8.4.8.2. Regulatory framework
    • 8.4.8.3. Competitive insights
    • 8.4.8.4. Sweden clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key country dynamic
    • 8.4.9.2. Regulatory framework
    • 8.4.9.3. Competitive insights
    • 8.4.9.4. Norway clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key country dynamic
    • 8.5.2.2. Regulatory framework
    • 8.5.2.3. Competitive insights
    • 8.5.2.4. Japan clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key country dynamic
    • 8.5.3.2. Regulatory framework
    • 8.5.3.3. Competitive insights
    • 8.5.3.4. China clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key country dynamic
    • 8.5.4.2. Regulatory framework
    • 8.5.4.3. Competitive insights
    • 8.5.4.4. India clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamic
    • 8.5.5.2. Regulatory framework
    • 8.5.5.3. Competitive insights
    • 8.5.5.4. South Korea clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key country dynamic
    • 8.5.6.2. Regulatory framework
    • 8.5.6.3. Competitive insights
    • 8.5.6.4. Australia clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key country dynamic
    • 8.5.7.2. Regulatory framework
    • 8.5.7.3. Competitive insights
    • 8.5.7.4. Thailand clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Clinical Wearable Monitoring Devices Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key country dynamic
    • 8.6.2.2. Regulatory framework
    • 8.6.2.3. Competitive insights
    • 8.6.2.4. Brazil clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key country dynamic
    • 8.6.3.2. Regulatory framework
    • 8.6.3.3. Competitive insights
    • 8.6.3.4. Argentina clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key country dynamic
    • 8.7.2.2. Regulatory framework
    • 8.7.2.3. Competitive insights
    • 8.7.2.4. South Africa clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key country dynamic
    • 8.7.3.2. Regulatory framework
    • 8.7.3.3. Competitive insights
    • 8.7.3.4. Saudi Arabia clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key country dynamic
    • 8.7.4.2. Regulatory framework
    • 8.7.4.3. Competitive insights
    • 8.7.4.4. UAE clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key country dynamic
    • 8.7.5.2. Regulatory framework
    • 8.7.5.3. Competitive insights
    • 8.7.5.4. Kuwait clinical wearable monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Market Position/Share Analysis, 2025
• 9.2. Company Categorization
• 9.3. Number of startups on the market
• 9.4. Notable investment and funding activities
• 9.5. Company Profiles/Listing
  • 9.5.1. Abbott Laboratories
    • 9.5.1.1. Overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Product benchmarking
    • 9.5.1.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.2. Dexcom, Inc.
    • 9.5.2.1. Overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Product benchmarking
    • 9.5.2.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.3. Masimo Corporation
    • 9.5.3.1. Overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Product benchmarking
    • 9.5.3.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.4. iRhythm Technologies, Inc.
    • 9.5.4.1. Overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Product benchmarking
    • 9.5.4.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.5. VitalConnect, Inc.
    • 9.5.5.1. Overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Product benchmarking
    • 9.5.5.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.6. BioIntelliSense, Inc.
    • 9.5.6.1. Overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Product benchmarking
    • 9.5.6.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.7. Koninklijke Philips N.V.
    • 9.5.7.1. Overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Product benchmarking
    • 9.5.7.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.8. GE HealthCare Technologies Inc.
    • 9.5.8.1. Overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Product benchmarking
    • 9.5.8.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.9. Medtronic (Corsano Health B.V.)
    • 9.5.9.1. Overview
    • 9.5.9.2. Financial performance
    • 9.5.9.3. Product benchmarking
    • 9.5.9.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.10. Empatica, Inc.
    • 9.5.10.1. Overview
    • 9.5.10.2. Financial performance
    • 9.5.10.3. Product benchmarking
    • 9.5.10.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.11. Biobeat Technologies Ltd.
    • 9.5.11.1. Overview
    • 9.5.11.2. Financial performance
    • 9.5.11.3. Product benchmarking
    • 9.5.11.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.12. VivaLNK, Inc.
    • 9.5.12.1. Overview
    • 9.5.12.2. Financial performance
    • 9.5.12.3. Product benchmarking
    • 9.5.12.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.13. Bardy Diagnostics, Inc. (Baxter)
    • 9.5.13.1. Overview
    • 9.5.13.2. Financial performance
    • 9.5.13.3. Product benchmarking
    • 9.5.13.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.14. Cardiac Insight, Inc.
    • 9.5.14.1. Overview
    • 9.5.14.2. Financial performance
    • 9.5.14.3. Product benchmarking
    • 9.5.14.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.15. Biofourmis, Inc.
    • 9.5.15.1. Overview
    • 9.5.15.2. Financial performance
    • 9.5.15.3. Product benchmarking
    • 9.5.15.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)
  • 9.5.16. LifeSignals, Inc.
    • 9.5.16.1. Overview
    • 9.5.16.2. Financial performance
    • 9.5.16.3. Product benchmarking
    • 9.5.16.4. Strategic initiatives (Including FDA Approvals, Merger & Acquisitions, Collaboration and Partnerships, Regional Expansions, Other notable impacting the market)